Vasculopathy in Hyperthyroid Rats and Targets for Drug Effects
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
2
Page:
281-291
Author(s):
Lin Yang and De-Zai Dai
Vascular Disease and Risk Factors in Chronic Kidney Disease
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
2
Page:
321-331
Author(s):
Johanna Kohlhagen and John Kelly
A Role for Endothelin-1 in Peripheral Vascular Disease
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
325-332
Author(s):
Janice C.S. Tsui and Michael R. Dashwood
Insulin Resistance, Obesity and the Metabolic Syndrome. Is there a Therapeutic Role for Endothelin-1 Antagonists?
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
359-363
Author(s):
Sidney G. Shaw and P. Jane Boden
Endothelin-1 and Human Platelets
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
393-399
Author(s):
I. Anita Jagroop, Stella S. Daskalopoulou and Dimitri P. Mikhailidis
Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
355-375
Author(s):
Antonis S. Manolis, Stylianos Tzeis, Kostas Triantafyllou, John Michaelidis, Ioannis Pyrros, Nikolaos Sakellaris, Athanasios Kranidis and Helen Melita
Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
377-386
Author(s):
Rupal Dumasia, Kim A. Eagle, Eva Kline-Rogers, Niquole May, Leslie Cho and Debabrata Mukherjee
The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
387-403
Author(s):
Polychronis Dilaveris, Georgios Giannopoulos, Andreas Synetos and Christodoulos Stefanadis
Homocysteine-Lowering Treatment in Coronary Heart Disease
Journal:
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume:
3
Page:
289-295
Author(s):
M. Cesari, G. P. Rossi and A. C. Pessina
Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome
Journal:
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume:
3
Page:
377-381
Author(s):
Y. Miyashita and K. Shirai